Raymond, Eric http://orcid.org/0000-0001-5491-2708
Thieblemont, Catherine
Alran, Severine
Faivre, Sandrine
Article History
First Online: 22 May 2020
Compliance with Ethical Standards
:
: No external funding was used in the preparation of this article.
: Eric Raymond has provided consulting for SCOR and Genoscience Pharma. Catherine Thieblemont declares Honoraria, Consulting, and an advisory role with Amgen, Celgene, Jazz Pharma, Kyte, Novartis, Servier, and Roche as well as institutional research funding from Roche, Celgene, and Hospira. Severine Alran and Sandrine Faivre declare that they have no conflicts of interest that might be relevant to the contents of this article.